Results showed that RAD51 was significantly associated with worse overall survivals in 11 cancer types, while RAD51 was associated with better overall survivals in rectum adenocarcinoma (READ) and thymoma (THYM) (Figure 4A). Here, RAD51 is linked to rectum adenocarcinoma.